Matt Burke

Matt Burke has a diverse work experience, starting with their current role as Vice President of Technical Operations & Product Development at Stemline Therapeutics since June 2022. Before that, they worked at Merck as a Director of mRNA Vaccine & Delivery Technologies from October 2021 to June 2022. Prior to Merck, they held various positions at Radius Health, Inc., including Vice President of Clinical Development and Pharmaceutical Sciences from March 2021 to October 2021, and Executive Director of Pharmaceutical Sciences from June 2019 to March 2021. From 2016 to 2019, they worked at GlaxoSmithKline as a Senior Director and later Director of Drug Delivery & CMC Leader. Before joining GlaxoSmithKline, they worked in different roles at the University of North Carolina at Chapel Hill and North Carolina State University as an Adjunct Professor. Matt Burke's work experience showcases their expertise in technical operations, product development, pharmaceutical sciences, drug delivery, and mRNA vaccine technologies.

Matt Burke earned their Doctor of Philosophy (Ph.D.) in Drug Delivery Systems from North Carolina State University, where they studied from 1997 to 2001.